Early initiation of three-drug combinations for the treatment of carbapenem-resistant <i>A. baumannii</i> among COVID-19 patients

Abstract

Use of three-drug regimens for severe CRAB infections among COVID-19 resulted in high rates of clinical response and low mortality relative to previous studies. The emergence of further antibiotic resistance was not detected phenotypically or through WGS analysis. Additional studies are needed to elucidate preferred antibiotic combinations linked to the molecular characteristics of infecting strains.